Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Bliss GVS Pharma has informed that it enclosed proceedings of the 36th Annual General Meeting held on Tuesday, September 21, 20201 at 11:00 am through Video Conferencing ('VC')/ Other Audio-Visual Means ('OAVM').
The above information is a part of company’s filings submitted to BSE.